| Dr Prajesh Adhikari, MD | |
|
350 W Thomas Rd, Phoenix, AZ 85013-4409 | |
| (602) 263-9007 | |
| Not Available |
| Full Name | Dr Prajesh Adhikari |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 12 Years |
| Location | 350 W Thomas Rd, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275893299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 62729 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regency Skin Institute Pllc | 5193097665 | 10 |
| Clin-path Pathology | 5193717866 | 32 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Entity Name | Pathology Specialist Of Arizona, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174503999 PECOS PAC ID: 4789583188 Enrollment ID: O20040105000801 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Entity Name | Clin-path Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922079706 PECOS PAC ID: 5193717866 Enrollment ID: O20040401000920 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Entity Name | St Josephs Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265407738 PECOS PAC ID: 5496730590 Enrollment ID: O20040622001577 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Entity Name | Regency Skin Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932630563 PECOS PAC ID: 5193097665 Enrollment ID: O20170817002453 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Entity Name | Pathology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992777601 PECOS PAC ID: 7214903939 Enrollment ID: O20211105001528 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Prajesh Adhikari, MD Po Box 42210, Phoenix, AZ 85080-2210 Ph: (602) 685-5166 | Dr Prajesh Adhikari, MD 350 W Thomas Rd, Phoenix, AZ 85013-4409 Ph: (602) 263-9007 |
News Archive
Conventional wisdom holds that as the U.S. population ages, the incidence of heart failure will continue to rise.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, today announced that it has commenced phase two of its grant study at the University of California, San Diego (UCSD) Moores Cancer Center.
A device that improves outcome in patients with coronary artery disease may be too expensive to use in all patients, suggests a study published early online and in the upcoming issue of The Lancet.
KLOX Technologies Inc. announces the approval in Canada of the Klox Biophotonic System (also known as the Lumigel Cleanse System) for the treatment of acne vulgaris after receiving this week a Medical Device License from the Therapeutic Products Directorate - Medical Devices Bureau of Health Canada
Oxford spinout EvOx Therapeutics will harness the body's own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
› Verified 6 days ago
Dr. Natasha Elizabeth Lewis, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Nasma Kamil Majeed, MD Pathology Medicare: Medicare Enrolled Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-685-5211 Fax: 623-322-4639 | |
David J Glembocki, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 11130 N Tatum Blvd, Suite 100, Phoenix, AZ 85028 Phone: 602-494-1817 Fax: 602-494-7103 | |
Suzan Kavusi, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Dr. Maria P Alzona, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 424 S 56th St Ste 120, Phoenix, AZ 85034 Phone: 602-685-5211 Fax: 602-685-5325 | |
Anna Marie Felty-duckworth, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Cs/113, Phoenix, AZ 85012 Phone: 602-277-5551 Fax: 602-222-2669 | |
Renuka Pathi, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 22216 N 36th St, Phoenix, AZ 85050 Phone: 602-606-7375 |